skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Clinical Trials remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis
Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Validity of Using Pathological Response as a Surrogate for Overall Survival in Neoadjuvant Studies for Esophageal Cancer: A Systematic Review and Meta-analysis

Su, Feng ; Yang, Xinyu ; Yin, Jun ; Shen, Yaxing ; Tan, Lijie

Annals of surgical oncology, 2023-11, Vol.30 (12), p.7461-7471 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
2
Association of Sequential Organ Failure Assessment (SOFA) components with mortality
Association of Sequential Organ Failure Assessment (SOFA) components with mortality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of Sequential Organ Failure Assessment (SOFA) components with mortality

Pölkki, Anssi ; Pekkarinen, Pirkka T. ; Takala, Jukka ; Selander, Tuomas ; Reinikainen, Matti

Acta anaesthesiologica Scandinavica, 2022-07, Vol.66 (6), p.731-741 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Neoadjuvant rectal score is prognostic for survival: A population‐based propensity‐matched analysis
Neoadjuvant rectal score is prognostic for survival: A population‐based propensity‐matched analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant rectal score is prognostic for survival: A population‐based propensity‐matched analysis

Naffouje, Samer A. ; Manguso, Nicholas ; Imanirad, Iman ; Sahin, Ibrahim H. ; Xie, Hao ; Hoffe, Sarah ; Frakes, Jessica ; Sanchez, Julian ; Dessureault, Sophie ; Felder, Seth

Journal of surgical oncology, 2022-12, Vol.126 (7), p.1219-1231 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial
Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial

Gilbert, Peter B. ; Fong, Youyi ; Hejazi, Nima S. ; Kenny, Avi ; Huang, Ying ; Carone, Marco ; Benkeser, David ; Follmann, Dean

Vaccine, 2024-04, Vol.42 (9), p.2181-2190 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Kreuter, Michael ; Del Galdo, Francesco ; Miede, Corinna ; Khanna, Dinesh ; Wuyts, Wim A ; Hummers, Laura K ; Alves, Margarida ; Schoof, Nils ; Stock, Christian ; Allanore, Yannick

Arthritis research & therapy, 2022-01, Vol.24 (1), p.19-19, Article 19 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design
Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design
Material Type:
Artigo 		Adicionar ao Meu Espaço

Surrogate marker assessment using mediation and instrumental variable analyses in a case-cohort design

Huang, Yen-Tsung ; Yu, Jih-Chang ; Lin, Jui-Hsiang

The annals of applied statistics, 2023-06, Vol.17 (2) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma

Dimopoulos, Meletios ; Sonneveld, Pieter ; Manier, Salomon ; Lam, Annette ; Roccia, Tito ; Schecter, Jordan M ; Cost, Patricia ; Pacaud, Lida ; Poirier, Abbey ; Tremblay, Gabriel ; Lan, Tommy ; Valluri, Satish ; Kumar, Shaji

BMC cancer, 2024-04, Vol.24 (1), p.541-541, Article 541 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma
Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma

Jin, Yuzhi ; Ren, Hui ; Yue, Qianhua ; Wu, Wei ; Liu, Chuan ; Guo, Yixuan ; Zhao, Peng

BMC cancer, 2024-02, Vol.24 (1), p.258-12, Article 258 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
9
Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings
Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings
Material Type:
Artigo 		Adicionar ao Meu Espaço

Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings

Hua, Tiantian ; Gao, Yuan ; Zhang, Ruyang ; Wei, Yongyue ; Chen, Feng

BMC cancer, 2022-09, Vol.22 (1), p.1-1022, Article 1022 [Periódico revisado por pares]

London: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Biomarkers for drug development in propionic and methylmalonic acidemias
Biomarkers for drug development in propionic and methylmalonic acidemias
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biomarkers for drug development in propionic and methylmalonic acidemias

Longo, Nicola ; Sass, Jörn Oliver ; Jurecka, Agnieszka ; Vockley, Jerry

Journal of inherited metabolic disease, 2022-03, Vol.45 (2), p.132-143 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (166)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (172)
  2. Book Chapters  (6)
  3. Livros  (2)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1999  (8)
  2. 1999Até2005  (13)
  3. 2006Até2011  (30)
  4. 2012Até2017  (43)
  5. Após 2017  (89)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (179)
  2. Japonês  (24)
  3. Francês  (5)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.